Dorothy Watson

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2008 · 990 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Everett E. Vokes, James E. Herndon, Michael J. Kelley et al. · Journal of Clinical Oncology · 2007 · 473 citations

Medicine, Oncology, Chemotherapy +14

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Rogério Lilenbaum, James E. Herndon, Marcy A. List et al. · Journal of Clinical Oncology · 2004 · 451 citations

Medicine, Oncology, Pharmacology +14

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2004 · 367 citations

Medicine, Oncology, Cancer Pharmacology +16

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon et al. · Clinical Cancer Research · 2005 · 259 citations

Medicine, Oncology, Pharmacology +14